Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
COMMACK, NY , March 19, 2018 -- Patient Access Solutions, Inc. (OTC PINK: PASO), a provider of healthcare/financial processing and management solutions for the healthcare, and dental industries, proudly announces it has retained the services of Triumph Investor Relations, an experienced and successful Investor Relations Firm, to assist the Company to increase visibility to the investment community, improve shareholder communications, and expand media relations.
Our management team remains dedicated to transparency and protecting our shareholders. We will continue to demonstrate our commitment to the future of PASO through positive steps at improving our shareholder value via the retention of services from third parties that can assist the Company onto the road to success.
Triumph Investor Relations, Inc. is a national marketing public relations firm with a reputation for delivering results to clients who seek and appreciate the individual attention only a boutique agency can provide. With offices in New York and Florida it allows them the latitude to get PASO in front of an endless amount of industry professionals.
Bruce Weitzberg, CEO of Patient Access Solutions Inc., stated, “We are looking forward to the exposure and recognition that Triumph brings the table. Their team of professionals is an absolute asset to the growth of PASO.”
About Patient Access Solutions Inc.(www.pashealth.com)
Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions company which has created a formidable array of technology, management resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. For more information about the services and products of Patient Access Solutions, please visit our website at www.pashealth.com.
About the CIIT Center (www.theciitcenter.com)
The CIIT Center occupies 12,500-square feet, in a street level office building located right off two major highways in Plainview, NY. The progressive center provides great efficiency and convenience in how we serve our patients. The goal is to create integrated, personalized treatment programs where the patient and staff work in unison to identify the underlying health conditions causing the issues, as opposed to just treating the symptoms.
About Triumph Investor Relations
Triumph utilizes a healthy mix of traditional grassroots campaigns and social media to ensure the results you need. The partners of Triumph have over 50 years’ experience in the industry and utilize their extensive rolodexes to benefit each of our portfolio companies. Our relationships with buy-side houses and research analysts from major investment banks have proven to be invaluable assets to the companies we support.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at http://www.sec.gov.
For more investor information please call; Craig Redding Triumph Investor Relations, LLC 11123 SW Wyndham Way Port St Lucie, FL 34987 772-713-5902 [email protected]
